Ascendis Pharma A/S is a new, privately held biotech company founded in December 2007.

Ascendis successfully completed its first-round of venture capital financing and acquired Complex Biosystems GmbH in December, 2007.

The Series A financing of EUR 17.6 million was led by Sofinnova Partners (France) with co-lead by Gilde Healthcare Partners (The Netherlands), and with participation by Zweite TechnoStart Ventures Fonds GmbH & Co. KG (Germany).

The proceeds from the Series A financing will be used to strategically broaden Ascendis` pipeline and to position itself in the space of lifecycle management of high-value, marketed drugs.

Ascendis` commercial headquarters is based in Copenhagen, Denmark. Its research organization, formerly known as Complex Biosystems, is located in Heidelberg, Germany and its Clinical & Regulatory Site is located in New Jersey, US. The expertise at three sites creates a continuum from discovery to clinical development and commercialization that facilitates rapid product development.